Skip to main content

Or 34,00 After 66% tax deduction

I make a monthly donation I make an IFI donation
Organoïde cortical en microscopie confocale

Cellular and molecular neurobiology

Research Area

Last update: 25/03/2026 Reading time: 1min
Retour à la recherche

The main objective of the teams in this area is to identify the genetic, molecular and cellular mechanisms that underlie brain function during development and aging.

This fundamental knowledge is essential for understanding major brain functions and neurological and psychiatric diseases in order to develop new therapeutic targets.

Mobilization of teams

Mobilization of teams

Paris Brain Institute teams in molecular and cellular neuroscience are engaged in a collaborative effort to understand normal brain and spinal cord development and the causes of their dysfunction in aging and neurological diseases (neurodegenerative diseases, multiple sclerosis, epilepsy, brain tumours, etc.).

Paris Brain Institute strategy is to assess the influence of genetics, dissect the molecular machinery of intracellular signaling, elucidate the role of different cell types, and understand complex cellular interactions in the normal or pathological state. The elucidation of the molecular and cellular bases of disorders of the nervous system allows us to understand the mechanisms of diseases and to develop new approaches to diagnose and treat them.

News that might interest you

TDAH : les troubles de l’attention sont associées à l’intrusion d’ondes du sommeil pendant l’éveil
ADHD: Attention difficulties are linked to the intrusion of sleep waves during wakefulness
Attention-deficit/hyperactivity disorder (ADHD) remains poorly understood from a biological perspective. An international study led by scientists from the Paris Brain Institute and Monash University in Australia suggests that some symptoms may be...
03.17.2026 Research, science & health
L’IRM structurelle ne permet pas, à elle seule, de diagnostiquer la dépression
Structural MRI alone cannot diagnose depression
Can brain imaging reveal whether a person is affected by depression? This question has driven research for many years. Changes in brain structure have indeed been observed in patients with depression, suggesting that structural MRI might one day help...
03.12.2026 Research, science & health
Épilepsie temporale : une nouvelle stratégie pour corriger l’activité électrique anormale
Temporal Lobe Epilepsy: A New Strategy to Correct Abnormal Electrical Activity
Many patients suffer from epilepsy that cannot be controlled by current medications. Surgical removal of epileptogenic brain regions is effective in only about half of cases, and not all patients are eligible for the procedure. For these individuals...
03.06.2026 Research, science & health
Stimuler les mitochondries pour doper la mémoire à long terme
Stimulating Mitochondria to Boost Long-Term Memory
An international team led by Jaime de Juan-Sanz at the Paris Brain Institute has shown that slightly increasing the metabolic capacity of neurons can enhance long-term memory in both fruit flies and mice. The study, published in Nature Metabolism...
02.24.2026 Research, science & health
Traitements anti-Alzheimer
Anti-Alzheimer Treatments: A Long-Term Beneficial Effect on Symptoms
There is currently no cure for Alzheimer's disease. The treatments available in France—which are not reimbursed—are known as symptomatic treatments, meaning that they act on the consequences of the disease rather than its underlying cause. In 2018...
02.19.2026 Research, science & health
État de mal épileptique
Status Epilepticus: New Insights Gained from National Health Data
The most severe form of epilepsy, status epilepticus is a high-risk neurological emergency. Yet its epidemiology remains poorly understood, particularly in France. By analyzing data from the French National Health Insurance system, compiled within...
02.19.2026 Research, science & health
See all our news